An Observational Cohort Study Of Treatment Patterns And Outcomes In Patients With HER2 Positive (Her2+) Metastatic Breast Cancer (SystHERs Registry (Systematic Therapies for HER2+ Metastatic Breast Cancer Study)).

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Distribution of patients receiving unique treatment regimen/sequence of treatment regimens

Outcome Time Frame:

Up to 8 years

Safety Issue:

No

Principal Investigator

Clinical Trials

Investigator Role:

Study Director

Investigator Affiliation:

Genentech

Authority:

United States: Food and Drug Administration

Study ID:

ML28257

NCT ID:

NCT01615068

Start Date:

June 2012

Completion Date:

December 2020

Related Keywords:

• Breast Cancer
• Breast Neoplasms